• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

369
65
48
46
18

COUNTRY

45
12
5
5
5

PRICE

296
549
1,012
1,445

PUBLISHED

79
124
495
1,445

PRODUCT TYPE

1,350
67
17
11

Central Nervous System

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

PRODUCT TITLE
Japanese Encephalitis - Pipeline Review, H2 2014 Japanese Encephalitis - Pipeline Review, H2 2014 - Product Thumbnail Image

Japanese Encephalitis - Pipeline Review, H2 2014

Japanese Encephalitis - Pipeline Review, H2 2014 Summary This, ‘Japanese Encephalitis - Pipeline Review, H2 2014’, provides an overview of the Japanese Encephalitis’s therapeutic pipeline. This report...

December 2014
FROM

Brain Injury - Pipeline Review, H2 2014

Brain Injury - Pipeline Review, H2 2014 Summary This, ‘Brain Injury - Pipeline Review, H2 2014’, provides an overview of the Brain Injury’s therapeutic pipeline. This report provides comprehensive...

December 2014
FROM

Tauopathies - Pipeline Review, H2 2014

Tauopathies - Pipeline Review, H2 2014 Summary This, ‘Tauopathies - Pipeline Review, H2 2014’, provides an overview of the Tauopathies’s therapeutic pipeline. This report provides comprehensive information...

December 2014
FROM
Alzheimer Disease - New Drugs, Markets and Companies Alzheimer Disease - New Drugs, Markets and Companies - Product Thumbnail Image

Alzheimer Disease - New Drugs, Markets and Companies

Alzheimer's disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable...

December 2014
FROM
Xenazine-Drug Insights,2014 Xenazine-Drug Insights,2014 - Product Thumbnail Image

Xenazine-Drug Insights,2014

“Xenazine - Drug Insights, 2014” provides Xenazine marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

December 2014
FROM
Maxalt-Drug Insights,2014 Maxalt-Drug Insights,2014 - Product Thumbnail Image

Maxalt-Drug Insights,2014

“Maxalt - Drug Insights, 2014” provides Maxalt marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical...

December 2014
FROM
Lamotrigine GSK-Drug Insights,2014 Lamotrigine GSK-Drug Insights,2014 - Product Thumbnail Image

Lamotrigine GSK-Drug Insights,2014

“Lamotrigine GSK - Drug Insights, 2014” provides Lamotrigine GSK marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the...

December 2014
FROM
Stilnox-Drug Insights,2014 Stilnox-Drug Insights,2014 - Product Thumbnail Image

Stilnox-Drug Insights,2014

“Stilnox - Drug Insights, 2014” provides Stilnox marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

December 2014
FROM
Methycobal Tablets-Drug Insights,2014 Methycobal Tablets-Drug Insights,2014 - Product Thumbnail Image

Methycobal Tablets-Drug Insights,2014

“Methycobal Tablets - Drug Insights, 2014” provides Methycobal Tablets marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates...

December 2014
FROM
Vandral-Drug Insights,2014 Vandral-Drug Insights,2014 - Product Thumbnail Image

Vandral-Drug Insights,2014

“Vandral - Drug Insights, 2014” provides Vandral marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

December 2014
FROM
Invega SR-Drug Insights,2014 Invega SR-Drug Insights,2014 - Product Thumbnail Image

Invega SR-Drug Insights,2014

“Invega SR - Drug Insights, 2014” provides Invega SR marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

December 2014
FROM
Diprivan EML-Drug Insights,2014 Diprivan EML-Drug Insights,2014 - Product Thumbnail Image

Diprivan EML-Drug Insights,2014

“Diprivan EML - Drug Insights, 2014” provides Diprivan EML marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US,...

December 2014
FROM

Neurotech Insights

Covering Drugs, Devices, and Diagnostics for the Brain and Nervous System On the first day of each month, Neurotech Insights is delivered to your inbox giving you competitive intelligence on...

December 2014
FROM
Latuda-Drug Insights,2014 Latuda-Drug Insights,2014 - Product Thumbnail Image

Latuda-Drug Insights,2014

“Latuda - Drug Insights, 2014” provides Latuda marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical...

December 2014
FROM
Risperdal Consta LP-Drug Insights,2014 Risperdal Consta LP-Drug Insights,2014 - Product Thumbnail Image

Risperdal Consta LP-Drug Insights,2014

“Risperdal Consta LP - Drug Insights, 2014” provides Risperdal Consta LP marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates...

December 2014
FROM
Abilify-Drug Insights,2014 Abilify-Drug Insights,2014 - Product Thumbnail Image

Abilify-Drug Insights,2014

“Abilify - Drug Insights, 2014” provides Abilify marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

December 2014
FROM
Xyrem-Drug Insights,2014 Xyrem-Drug Insights,2014 - Product Thumbnail Image

Xyrem-Drug Insights,2014

“Xyrem - Drug Insights, 2014” provides Xyrem marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical...

December 2014
FROM
Namenda-Drug Insights,2014 Namenda-Drug Insights,2014 - Product Thumbnail Image

Namenda-Drug Insights,2014

“Namenda - Drug Insights, 2014” provides Namenda marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

December 2014
FROM
Adderall-Drug Insights,2014 Adderall-Drug Insights,2014 - Product Thumbnail Image

Adderall-Drug Insights,2014

“Adderall XR - Drug Insights, 2014” provides Adderall XR marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

December 2014
FROM
Requip IR-Drug Insights,2014 Requip IR-Drug Insights,2014 - Product Thumbnail Image

Requip IR-Drug Insights,2014

“Requip IR - Drug Insights, 2014” provides Requip IR marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

December 2014
FROM
Loading Indicator

Our Clients

Our clients' logos